Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF‐κB, JAK/STAT, and MAPK signaling pathways
Saeed Mohammadian Haftcheshmeh, Maliheh Abedi, Kazem Mashayekhi, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 3, pp. 1216-1230
Closed Access | Times Cited: 78
A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1294-1294
Open Access | Times Cited: 36
Biologically active isoquinoline alkaloids covering 2019–2022
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 10
Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review
Arian Khoshandam, Mohsen Imenshahidi, Hossein Hosseinzadeh
Phytotherapy Research (2022) Vol. 36, Iss. 11, pp. 4063-4079
Closed Access | Times Cited: 37
Major Achievements in the Design of Quadruplex-Interactive Small Molecules
Eduarda Mendes, Israa M. Aljnadi, Bárbara Bahls, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 300-300
Open Access | Times Cited: 35
Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking
Jun‐Feng Cao, Lianglei Li, Li Xiong, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 2, pp. 100252-100252
Open Access | Times Cited: 32
The role of berberine in Covid-19: potential adjunct therapy
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 32
A bird's eye view on a therapeutically ‘wonder molecule’: Berberine
Parth Patel
Phytomedicine Plus (2021) Vol. 1, Iss. 3, pp. 100070-100070
Open Access | Times Cited: 33
COVID-19 inflammation and implications in drug delivery
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 260-274
Open Access | Times Cited: 24
Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
Ke Li, Xiuhua Yu, Anish Maskey, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 14
Binding Properties of RNA Quadruplex of SARS-CoV-2 to Berberine Compared to Telomeric DNA Quadruplex
Rosario Oliva, Sanjib Mukherjee, Magiliny Manisegaran, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5690-5690
Open Access | Times Cited: 22
Research and development of Chinese anti-COVID-19 drugs
Xiwei Ji, Xiangrui Meng, Xiao Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4271-4286
Open Access | Times Cited: 19
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Berberine Suppresses Influenza A Virus-Triggered Pyroptosis in Macrophages via Intervening in the mtROS-MAVS-NLRP3 Inflammasome Pathway
Mengfan Zhao, Di Deng, Hui Liu, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 539-539
Open Access
Targeting autophagy with natural products to prevent SARS-CoV-2 infection
Chiara Vidoni, Andréa D. Fuzimoto, Alessandra Ferraresi, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 55-68
Open Access | Times Cited: 24
Methodology of network pharmacology for research on Chinese herbal medicine against COVID-19: A review
Yixuan Wang, Zhen Yang, Wen-xiao Wang, et al.
Journal of Integrative Medicine (2022) Vol. 20, Iss. 6, pp. 477-487
Open Access | Times Cited: 18
Bile acids and coronavirus disease 2019
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6083-6083
Open Access | Times Cited: 15
Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19
Qiying Jin, Wanxi Li, Wendi Yu, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106134-106134
Open Access | Times Cited: 14
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 8
Successful Treatment of a Patient With Severe COVID-19 Using an Integrated Approach Addressing Mast Cells and Their Mediators
Theoharis C. Theoharides, Lucy Guerra, K. Patel
International Journal of Infectious Diseases (2022) Vol. 118, pp. 164-166
Open Access | Times Cited: 13
Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017–2023)
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, et al.
ACS Pharmacology & Translational Science (2023) Vol. 7, Iss. 1, pp. 48-71
Closed Access | Times Cited: 7
Exploring the Therapeutic Potential of Petiveria alliacea L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2’s Main Protease (Mpro)
Md. Ahad Ali, Humaira Sheikh, Muhammad Yaseen, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2524-2524
Open Access | Times Cited: 2
Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways
Anish Maskey, Daniel Kopulos, Matthew D. Kwan, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1639-1639
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top